AVDV vs IBB
Avantis International Small Cap Value ETF vs iShares Biotechnology ETF
- • AVDV has the lower expense ratio at 0.36% vs 0.44% for IBB.
- • AVDV pays a higher dividend yield (2.83%).
Side-by-side metrics
| Metric | AVDV | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.36% | 0.44% |
Dividend yield Trailing 12-month yield. | 2.83% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $19.22B | $9.09B |
YTD return | 11.26% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.96 | 0.69 |
P/E ratio | 13.41 | 24.79 |
Last price | $103.29 | $196.62 |
Inception | — | — |
Issuer | Avantis | iShares |
AVDV top holdings
| ATS.VI | AT&S Austria Technologie & Systemtechnik AG | 2.56% |
| 5706.T | Mitsui Kinzoku Co Ltd | 1.17% |
| SPM.MI | Saipem SpA | 0.59% |
| PRU.AX | Perseus Mining Ltd | 0.57% |
| CLIS.TA | Clal Insurance Enterprises Holdings Ltd | 0.56% |
| JMAT.L | Johnson Matthey PLC | 0.56% |
| BTO.TO | B2Gold Corp | 0.55% |
| BGEO.L | Lion Finance Group PLC | 0.55% |
| CDE | Coeur Mining Inc | 0.54% |
| HBM.TO | Hudbay Minerals Inc | 0.53% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About AVDV
AVDV (Avantis International Small Cap Value ETF) is International developed small-cap value stocks. Managed by Avantis, the fund carries $19.2B in assets under management, an expense ratio of 0.36%, a dividend yield of 2.83%. Its largest holding is AT&S Austria Technologie & Systemtechnik AG (ATS.VI), which represents 2.6% of the portfolio. Real Estate is the fund's largest sector exposure at 1.2%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.